COVID-19 candidate vaccine induces strong immune response; late-stage trial to start July 23

Wednesday, July 15, 2020 - 03:30 in Health & Medicine

U.S. biotech company Moderna said a vaccine it is developing has shown to induce a "rapid and strong" immune response against COVID-19, stating it will begin late-stage testing in less than two weeks.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net